The Role of MAP Kinase Phosphatase-1 in the Protective Mechanism of Dexamethasone Against Endotoxemia

Overview

Journal Life Sci

Publisher Elsevier

Specialties Biochemistry
Biology
Physiology

Date 2008 Oct 11

PMID 18845168

Citations 35

Authors

Xianxi Wang

Leif D Nelin

Joshua R Kuhlman

Xiaomei Meng

Stephen E Welty

Yusen Liu

Affiliations

Soon will be listed here.

Abstract

Aims: We have previously shown that glucocorticoids induce the expression of MAP kinase phosphatase (Mkp)(a)-1 in innate immune cells. Since Mkp-1 is a critical negative regulator of the innate immune response, we hypothesize that Mkp-1 plays a significant role in the anti-inflammatory action of glucocorticoids. The specific aim of the present study is to understand the role of Mkp-1 in the anti-inflammatory function of glucocorticoids.

Main Methods: Wild-type and Mkp-1(-/-) mice were treated with different doses of dexamethasone and then challenged with different doses of lipopolysaccharide (LPS). The survival and blood cytokines were assessed. The effects of dexamethasone on cytokine production in wild-type and Mkp-1(-/-) primary macrophages ex vivo were also examined.

Key Findings: We found that dexamethasone induced the expression of Mkp-1 in vivo. Dexamethasone treatment completely protected wild-type mice from the mortality caused by a relatively high dose of LPS. However, dexamethasone treatment offered only a partial protection to Mkp-1(-/-) mice. Dexamethasone attenuated TNF-alpha production in both wild-type and Mkp-1(-/-) mice challenged with LPS, although TNF-alpha production in Mkp-1(-/-) mice was significantly more robust than that in wild-type mice. Dexamethasone pretreatment shortened the duration of p38 and JNK activation in LPS-stimulated wild-type macrophages, but had little effect on p38 or JNK activation in similarly treated Mkp-1(-/-) macrophages.

Significance: Our results indicate that the inhibition of p38 and JNK activities by glucocorticoids is mediated by enhanced Mkp-1 expression. These results demonstrate that dexamethasone exerts its anti-inflammatory effects through both Mkp-1-dependent and Mkp-1-indepent mechanisms.

Citing Articles

The E3 Ubiquitin Protein Ligase LINCR Amplifies the TLR-Mediated Signals through Direct Degradation of MKP1.

Yokosawa T, Miyagawa S, Suzuki W, Nada Y, Hirata Y, Noguchi T Cells. 2024; 13(8.

PMID: 38667302 PMC: 11048823. DOI: 10.3390/cells13080687.

Causal associations between circulating cytokines and risk of sepsis and related outcomes: a two-sample Mendelian randomization study.

Zhi F, Ma J, Ji D, Bao J, Li Q Front Immunol. 2024; 15:1336586.

PMID: 38504987 PMC: 10948396. DOI: 10.3389/fimmu.2024.1336586.

MIF modulates p38/ERK phosphorylation via MKP-1 induction in sarcoidosis.

Talreja J, Peng C, Samavati L iScience. 2024; 27(1):108746.

PMID: 38299032 PMC: 10829885. DOI: 10.1016/j.isci.2023.108746.

Dexamethasone impairs the expression of antimicrobial mediators in lipopolysaccharide-activated primary macrophages by inhibiting both expression and function of interferon β.

ONeil J, Bolimowska O, Clayton S, Tang T, Daley K, Lara-Reyna S Front Immunol. 2023; 14:1190261.

PMID: 37942320 PMC: 10628473. DOI: 10.3389/fimmu.2023.1190261.

MKP-1 modulates ubiquitination/phosphorylation of TLR signaling.

Talreja J, Bauerfeld C, Wang X, Hafner M, Liu Y, Samavati L Life Sci Alliance. 2021; 4(12).

PMID: 34580177 PMC: 8500224. DOI: 10.26508/lsa.202101137.

References

Xu Q, Fawcett T, Gorospe M, Guyton K, Liu Y, Holbrook N . Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension. Hypertension. 1997; 30(1 Pt 1):106-11. DOI: 10.1161/01.hyp.30.1.106. View

Annane D, Sebille V, Charpentier C, Bollaert P, Francois B, Korach J . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288(7):862-71. DOI: 10.1001/jama.288.7.862. View

Annane D, Cavaillon J . Corticosteroids in sepsis: from bench to bedside?. Shock. 2003; 20(3):197-207. DOI: 10.1097/01.shk.0000079423.72656.2f. View

Parrillo J . Pathogenetic mechanisms of septic shock. N Engl J Med. 1993; 328(20):1471-7. DOI: 10.1056/NEJM199305203282008. View

Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A . Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993; 177(2):547-50. PMC: 2190913. DOI: 10.1084/jem.177.2.547. View

BERRY L, Smythe D . EFFECTS OF BACTERIAL ENDOTOXINS ON METABOLISM. VII. ENZYME INDUCTION AND CORTISONE PROTECTION. J Exp Med. 1964; 120:721-32. PMC: 2137857. DOI: 10.1084/jem.120.5.721. View

Goulding N . The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr Opin Pharmacol. 2004; 4(6):629-36. DOI: 10.1016/j.coph.2004.06.009. View

Abraham S, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J . Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med. 2006; 203(8):1883-9. PMC: 2118371. DOI: 10.1084/jem.20060336. View

Kontoyiannis D, Pasparakis M, Pizarro T, Cominelli F, Kollias G . Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 1999; 10(3):387-98. DOI: 10.1016/s1074-7613(00)80038-2. View

10.

Bhattacharyya S, Brown D, Brewer J, Vogt S, Muglia L . Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood. 2007; 109(10):4313-9. PMC: 1885507. DOI: 10.1182/blood-2006-10-048215. View

11.

Joyce D, Gimblett G, Steer J . Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflamm Res. 2001; 50(7):337-40. DOI: 10.1007/PL00012387. View

12.

Zhao Q, Shepherd E, Manson M, Nelin L, Sorokin A, Liu Y . The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem. 2004; 280(9):8101-8. DOI: 10.1074/jbc.M411760200. View

13.

Han J, Thompson P, Beutler B . Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med. 1990; 172(1):391-4. PMC: 2188134. DOI: 10.1084/jem.172.1.391. View

14.

Salojin K, Owusu I, Millerchip K, Potter M, Platt K, Oravecz T . Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol. 2006; 176(3):1899-907. DOI: 10.4049/jimmunol.176.3.1899. View

15.

Dorfman K, Carrasco D, Gruda M, Ryan C, Lira S, Bravo R . Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene. 1996; 13(5):925-31. View

16.

Annane D . Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care. 2005; 11(5):449-53. DOI: 10.1097/01.ccx.0000176691.95562.43. View

17.

Chen P, Li J, Barnes J, Kokkonen G, Lee J, Liu Y . Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol. 2002; 169(11):6408-16. DOI: 10.4049/jimmunol.169.11.6408. View

18.

Saklatvala J . Glucocorticoids: do we know how they work?. Arthritis Res. 2002; 4(3):146-50. PMC: 128923. DOI: 10.1186/ar398. View

19.

Swantek J, Cobb M, Geppert T . Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol. 1997; 17(11):6274-82. PMC: 232478. DOI: 10.1128/MCB.17.11.6274. View

20.

Raz E . Organ-specific regulation of innate immunity. Nat Immunol. 2006; 8(1):3-4. DOI: 10.1038/ni0107-3. View